Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Deciding which card is better, cash back or rewards, requires consideration of your spending habits. Make the right choice for your finances.
26,157 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Microsoft’s Satya Nadella signals a data-centric AI strategy, arguing buyers must reveal proprietary know-how to unlo...
With a 0.15% expense ratio, QQQM offers a cheaper path to Nasdaq-100 exposure. The potential cost savings could meani...
AI-driven data centers are keeping DRAM prices high as demand for high-bandwidth memory tightens supply. Market obser...
A federal judge dismissed a lawsuit alleging Buffalo Wild Wings misled customers with the word 'boneless wings.' The ...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
Pippin jumps 20% in a single session, bucking a broad market dip. The meme coin climbs near $0.71 with a $710 million...
MercadoLibre posted a solid Q4 revenue beat alongside an earnings miss, underscoring margin pressure from growth init...
Axiom Exchange is under fire after a leaked call and claims that an employee accessed private wallets and user data. ...
The Humanoid Robotics ETF BOTT surged 114% in the last year, yet its concentrated Korean and Chinese holdings expose ...
A Switzerland-registered firm launches the $BANK token on Solana, offering on-chain exposure to a professionally mana...
shark tank’s kevin o’leary identifies two booming opportunities in AI for 2026: helping small businesses deploy AI to...